Key Takeaways
- HP Inc. rallied 15% following Lenovo’s exceptional quarter where approximately 40% of sales stemmed from AI-enabled devices
- JPMorgan upgraded its price forecast while maintaining a Neutral stance, partially reversing its October 2026 bearish call
- The options market anticipates a 9.8% volatility swing surrounding HP’s fiscal Q2 announcement on May 27
- Wall Street forecasts approximately $14 billion in revenue (7.2% growth YoY) alongside $0.71 EPS, unchanged from prior year
- Current analyst sentiment leans Moderate Sell—four Hold ratings, four Sell ratings—with a consensus target of $18.75
Last Friday witnessed HP Inc. soar 15%. The catalyst? Not an HP announcement—but Lenovo’s blockbuster performance.
The globe’s leading PC manufacturer, Lenovo, delivered its most impressive revenue expansion in half a decade. Artificial intelligence products accounted for nearly 40% of total sales. This single metric triggered HPQ’s dramatic climb.
Both HP and Lenovo target identical enterprise customers, utilize overlapping distribution networks, and capitalize on synchronized hardware refresh windows. When Lenovo delivers such commanding results, investors naturally extrapolate similar momentum for HP.
Acting on this correlation wasn’t without significant financial commitment.
JPMorgan’s Samik Chatterjee had already elevated his HPQ price objective days before Lenovo’s disclosure. His Neutral assessment remained unchanged. Previously, in October 2025, he downgraded the shares, cautioning that the Windows 10 replacement cycle was exhausting itself and HP would confront challenging year-over-year comparisons throughout 2026.
His revised target represents a subtle retreat from that bearish stance—not a complete reversal, merely a recalibration.
Analyst opinions remain fragmented. Morgan Stanley likewise increased its projection modestly. Bank of America held its pessimistic view, forecasting potential full-year guidance reductions when HP unveils results Wednesday.
Critical Metrics for the May 27 Report
HP unveils fiscal Q2 performance after market hours on May 27. Consensus projections call for approximately $14 billion in sales, representing 7.2% year-over-year expansion. Earnings per share are anticipated at $0.71, matching last year’s comparable period.
HP has exceeded earnings projections in just four of its last eight quarterly reports.
The truly pivotal metric transcends simple beats or misses—it’s the AI-capable PC penetration rate. Previous quarter data showed roughly one-third of HP’s PC shipments incorporated dedicated neural processing units. Should this percentage advance materially this quarter, particularly within commercial segments, the investment narrative transforms fundamentally.
Should penetration stagnate, Friday’s surge becomes a false signal.
Derivatives traders are positioning for substantial volatility. The implied movement embedded in options pricing stands at 9.8%. This represents considerable expected movement for HPQ shares.
The Valuation Argument Skeptics Overlook
HPQ commands a single-digit forward price-to-earnings ratio while delivering a dividend yield approaching 5%. The S&P 500 yields approximately 1.05% by comparison.
When a security yields nearly quadruple the benchmark index, markets have essentially written off meaningful growth prospects. Throughout the trailing twelve months, the S&P 500 has appreciated roughly 27%. HPQ has declined approximately 24% across the identical timeframe. Despite Friday’s 15% spike, HPQ remains down about 5% year-to-date.
This valuation framework suggests a multiple expansion doesn’t require exceptional results. It merely demands evidence undermining the bearish thesis.
Bulls require five confirmations from Wednesday’s release: sequential AI PC mix improvement, sustained commercial sector strength, margin preservation despite memory component inflation, stabilization of U.S. market position following recent erosion, and reaffirmation of full-year projections.
Falling short on two metrics likely erodes the rally. Achieving four could render JPMorgan’s target conservative.
Wall Street’s prevailing consensus rates HPQ as Moderate Sell, establishing an average price objective of $18.75—suggesting 25.7% appreciation potential from present valuations.


